A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jennifer Rachel Eads, Michelle Weitz, Michael K. Gibson, Lakshmi Rajdev, Onkar V Khullar, Steven H. Lin, Constantine Gatsonis, Ignacio Ivan Wistuba, Aravind Sanjeevaiah, Al Bowen Benson, Nathan Bahary, Kristen Renee Spencer, Nabil F. Saba, Stanley R. Hamilton, Charles A. Staley, Anuradha Bapsi Chakravarthy, Terence Z. Wong, Peter J. O'Dwyer
Institutions: University of Pennsylvania, Dana-Farber Cancer Institute, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center, Winship Cancer Institute, The University of Texas MD Anderson Cancer Center, Brown University, The University of Texas Southwestern Medical Center, Northwestern Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Rutgers Cancer Institute, City Of Hope National Medical Center, Duke Medical Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W3030828745